Ochsner Has Only FACT-Accredited Site for Adults in Louisiana
New Orleans, LA – The Ochsner Medical Center Leukemia, Blood and Marrow Transplantation Program has received internationally-recognized accreditation by the Foundation for the Accreditation of Cellular Therapy (FACT) at the University of Nebraska Medical Center. By demonstrating compliance with the FACT-JACIE International Standards for Cellular Therapy Product Collection, Processing and Administration, Ochsner Medical Center has earned FACT Accreditation for adult autologous hematopoietic progenitor cell transplantation; peripheral blood cellular therapy product collection; and cellular therapy product processing.
Ochsner is the only FACT-accredited site for adults in the state of Louisiana.
FACT is an internationally-recognized accrediting body for hospitals and medical institutions offering stem cell transplant, and indicates the accredited institution has met the most rigorous standards in every aspect of stem cell therapy. This covers the entire spectrum of stem cell therapy, from clinical care to donor management, cell collection, processing, storage, transportation, administration and cell release.
FACT-JACIE Standards are defined by leading experts based on the latest knowledge of the field of cellular therapy transplantation. Following an on-site evaluation, Ochsner Medical Center was found to be in compliance with these rigorous standards as well as governmental regulations.
“Receiving this accreditation is a testament to the dedication to excellence held by every member of our team,” said Robert Emmons, M.D., FACP, Director of the Ochsner Leukemia, Blood and Marrow Transplantation Program. “FACT accreditation is highly recognized and respected and allows patients insight into the high quality medical care provided at the Ochsner Cancer Institute.”
“We are pleased that the Ochsner Leukemia, Blood and Marrow Transplantation Program has met the requirements of the Foundation and has been granted accreditation,” said Dr. Phyllis Warkentin, FACT’s Chief Medical Officer.
Ochsner’s comprehensive Leukemia, Blood and Bone Marrow Transplantation Program provides the full range of care and treatment from diagnosis to long-term follow-up of all adult hematologic malignancies. A unique collaboration among a multidisciplinary team of highly trained and experienced physicians from Ochsner and LSU Health Science Center provide optimal care for oncology patients with leukemia, lymphoma, myeloma, aplastic anemia and certain immune deficiency diseases.
In addition, the hospital’s comprehensive hematology facility is specifically designed with hepa filtration and positive air pressure to reduce risk of patient infection. The stem cell laboratory, part of the Ochsner Blood Bank, was fully equipped as a free-standing stem cell processing laboratory to facilitate transplants. A dedicated outpatient infusion suite supports the transfusion needs of leukemia and transplant patients, as well.
The FACT accreditation is the latest in a string of national recognition for the Ochsner Cancer Institute (OCI). OCI again received three year accreditation by the The American College of Surgeons Commission on Cancer and Ochsner’s Lieselotte Tansey Breast Center again was granted three year full accreditation by the National Accreditation Program for Breast Centers.
The Ochsner Cancer Institute is the largest system in the Gulf South region to truly provide multidisciplinary care for adult and pediatric cancer patients, who benefit from a collaborative approach to cancer care by a highly skilled team of physicians, oncology nurses, social workers, researchers, and other health care professionals. Cancer patients receive their care in the state-of-the-art Gayle and Tom Benson Cancer Center which provides a relaxing atmosphere overlooking the Mississippi River. In 2012 alone, Ochsner diagnosed and treated nearly 3,200 patients.
Through the Ochsner Community Clinical Oncology Program (CCOP), patients have the opportunity to participate in clinical research trials from multiple collaborative groups. In fact, Ochsner is currently the largest clinical research program in oncology in the New Orleans region, providing access to trials at our Jefferson Highway, Baton Rouge, Covington and Baptist sites with plans to expand into our other locations in the future.
The Ochsner Cancer Institute was recognized as High Performing by U.S. News and World Report’s “Best Hospitals” awards in 2012 and named one of 100 Hospitals and Health Systems with Great Oncology Programs by Becker’s Hospital Review. Additionally, the radiation oncology program at Ochsner is fully accredited by the American College of Radiology (ACR).
For more information, please visit ochsner.org/cancer or call 504-842-3910.
About Ochsner Health System
Ochsner Health System is southeast Louisiana’s largest non-profit, academic, multi-specialty, healthcare delivery system. Driven by a mission to Serve, Heal, Lead, Educate and Innovate, coordinated clinical and hospital patient care is provided across the region by nine hospitals, both owned and managed, and more than 40 health centers in Louisiana. Ochsner has been named the Consumer Choice for Healthcare in New Orleans for 17 consecutive years and is the only Louisiana hospital recognized by U.S. News & World Report as a “Best Hospital” across 11 specialty categories. Ochsner employs more than 14,000 employees, over 900 physicians in over 90 medical specialties and subspecialties and conducts over 300 clinical research trials annually. Ochsner Health System is proud to be a tobacco-free environment. For more information, please visit ochsner.org and follow us on Twitter and Facebook.
In December 1994, the International Society for Cellular Therapy (ISCT) and the American Society for Blood and Marrow Transplantation (ASBMT) merged their Standards into a single document covering all aspects of hematopoietic cell therapy (collection, processing and transplantation). The two societies established FACT in order to develop a voluntary Inspection and Accreditation Program based on the joint Standards. FACT promotes quality medical and laboratory practice of cellular therapy through its peer-developed standards and voluntary inspection and accreditation program.
In 2006, FACT, in collaboration with the Joint Accreditation Committee – ISCT & EBMT (JACIE), developed international standards in the field of cellular therapy. JACIE was founded by the European Group for Blood and Marrow Transplantation (EBMT) and the International Society for Cellular Therapy (ISCT), the two leading scientific organizations involved with cellular transplantation in Europe.
Since 2007, FACT accreditation has been used in determining the U.S. News & World Report rankings of transplant centers for the “America’s Best Hospitals” and “America’s Best Children’s Hospitals” list.The FACT Inspection and Accreditation Program was developed by Dr. Phylis Warkentin, Chief Medical Officer of FACT, the FACT Board of Directors, as well as the ISCT and ASBMT Regulatory and Standards Committees. The first edition of the FACT Standards was published in September 1996, and the first inspections began in September of 1997 resulting in the first program being awarded accreditation in 1998.